Mark V. Sherrid

11.0k total citations · 2 hit papers
127 papers, 4.4k citations indexed

About

Mark V. Sherrid is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Mark V. Sherrid has authored 127 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Cardiology and Cardiovascular Medicine, 28 papers in Surgery and 22 papers in Epidemiology. Recurrent topics in Mark V. Sherrid's work include Cardiomyopathy and Myosin Studies (94 papers), Cardiovascular Function and Risk Factors (56 papers) and Cardiovascular Effects of Exercise (38 papers). Mark V. Sherrid is often cited by papers focused on Cardiomyopathy and Myosin Studies (94 papers), Cardiovascular Function and Risk Factors (56 papers) and Cardiovascular Effects of Exercise (38 papers). Mark V. Sherrid collaborates with scholars based in United States, Italy and United Kingdom. Mark V. Sherrid's co-authors include Daniel G. Swistel, Barry J. Maron, Farooq A. Chaudhry, David Z. Gunsburg, Sandhya K. Balaram, Ivan Barač, Susan A. Casey, Bette Kim, Glenda Winson and Martin S. Maron and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark V. Sherrid

121 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy

2022 249 citations Barry J. Maron, Milind Y. Desai et al. Journal of the American College of Cardiology profile →
Management of Hypertrophic Cardiomyopathy

2022 186 citations Barry J. Maron, Milind Y. Desai et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark V. Sherrid United States	36	4.1k	942	848	431	285	127	4.4k
Christine H. Attenhofer Jost Switzerland	27	2.4k 0.6×	841 0.9×	933 1.1×	163 0.4×	454 1.6×	56	3.0k
Piers E.F. Daubeney United Kingdom	20	1.6k 0.4×	644 0.7×	743 0.9×	178 0.4×	523 1.8×	59	2.3k
Ricardo H. Pignatelli United States	29	2.4k 0.6×	763 0.8×	1.4k 1.7×	324 0.8×	671 2.4×	102	3.6k
Susan W. Denfield United States	31	2.5k 0.6×	1.2k 1.3×	823 1.0×	89 0.2×	560 2.0×	152	3.6k
Fernando M. Picchio Italy	29	1.6k 0.4×	657 0.7×	1.4k 1.7×	129 0.3×	260 0.9×	80	2.6k
Alan Nugent United States	22	1.5k 0.4×	604 0.6×	1.0k 1.2×	169 0.4×	277 1.0×	74	2.2k
Minmin Lü United States	25	1.2k 0.3×	1.2k 1.3×	1.1k 1.3×	91 0.2×	320 1.1×	89	2.4k
Maully J. Shah United States	24	1.3k 0.3×	437 0.5×	655 0.8×	40 0.1×	239 0.8×	115	1.8k
Melanie D. Everitt United States	26	1.3k 0.3×	1.3k 1.4×	719 0.8×	56 0.1×	273 1.0×	98	2.4k
Stephan Schubert Germany	26	598 0.1×	656 0.7×	836 1.0×	212 0.5×	157 0.6×	95	1.9k

Countries citing papers authored by Mark V. Sherrid

Since Specialization

Citations

This map shows the geographic impact of Mark V. Sherrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Sherrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Sherrid more than expected).

Fields of papers citing papers by Mark V. Sherrid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark V. Sherrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Sherrid. The network helps show where Mark V. Sherrid may publish in the future.

Co-authorship network of co-authors of Mark V. Sherrid

This figure shows the co-authorship network connecting the top 25 collaborators of Mark V. Sherrid. A scholar is included among the top collaborators of Mark V. Sherrid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark V. Sherrid. Mark V. Sherrid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sherrid, Mark V., Daniele Massera, Samuel Bernard, et al.. (2024). Clinical Course and Treatment of Patients With Apical Aneurysms Due to Hypertrophic Cardiomyopathy. JACC Advances. 3(10). 101195–101195. 2 indexed citations

Desai, Milind Y., Kathy Wolski, Anjali Owens, et al.. (2024). Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM. Circulation. 151(19). 1378–1390. 14 indexed citations

Razzouk, Louai, et al.. (2023). Acute Left Ventricular Ballooning: Tools to Differentiate Hypertrophic Cardiomyopathy with Outflow Obstruction from Neurohumoral Takotsubo Syndrome. Reviews in Cardiovascular Medicine. 24(5). 154–154. 2 indexed citations

Sherrid, Mark V., Youssef Elnabawi, Leon Axel, et al.. (2023). Anatomic Correlates of Mitral Systolic Anterior Motion in Transposition of the Great Arteries Following Atrial Switch Operation. Congenital Heart Disease. 18(3). 267–277.

Arabadjian, Milla, et al.. (2023). Clinical course and outcomes in adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review protocol. BMJ Open. 13(7). e075087–e075087. 3 indexed citations

Sherrid, Mark V., Samuel Bernard, Nidhi Tripathi, et al.. (2023). Apical Aneurysms and Mid–Left Ventricular Obstruction in Hypertrophic Cardiomyopathy. JACC. Cardiovascular imaging. 16(5). 591–605. 20 indexed citations

Troy, Aaron L., Navneet Narula, Daniele Massera, et al.. (2023). Histopathology of the Mitral Valve Residual Leaflet in Obstructive Hypertrophic Cardiomyopathy. JACC Advances. 2(3). 100308–100308. 5 indexed citations

Desai, Milind Y., Anjali Owens, Jeffrey B. Geske, et al.. (2022). Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 147(11). 850–863. 53 indexed citations

Sherrid, Mark V., Daniel G. Swistel, Iacopo Olivotto, et al.. (2021). Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 10(20). e021141–e021141. 19 indexed citations

10.

Owens, Anjali, Mark V. Sherrid, Timothy C. Wong, et al.. (2021). Abstract 9685: Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study. Circulation. 144(Suppl_1). 8 indexed citations

11.

Sherrid, Mark V., Barry P. Rosenzweig, Daniele Massera, et al.. (2020). Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome. The American Journal of Cardiology. 125(11). 1700–1709. 17 indexed citations

12.

Hausvater, Anaïs, et al.. (2019). SPONTANEOUS CORONARY ARTERY DISSECTION IN PATIENTS WITH A PROVISIONAL DIAGNOSIS OF TAKOTSUBO SYNDROME. Journal of the American College of Cardiology. 73(9). 33–33. 3 indexed citations

13.

Sherrid, Mark V., et al.. (2017). State Requirements for Automated External Defibrillators in American Schools. Journal of the American College of Cardiology. 69(13). 1735–1743. 18 indexed citations

14.

Ro, Richard, Dan G. Halpern, David J. Sahn, et al.. (2014). Vector Flow Mapping in Obstructive Hypertrophic Cardiomyopathy to Assess the Relationship of Early Systolic Left Ventricular Flow and the Mitral Valve. Journal of the American College of Cardiology. 64(19). 1984–1995. 106 indexed citations

15.

Swistel, Daniel G., Joseph J. DeRose, & Mark V. Sherrid. (2004). Management of patients with complex hypertrophic cardiomyopathy: Resection/plication/release. Operative Techniques in Thoracic and Cardiovascular Surgery. 9(4). 261–267. 13 indexed citations

16.

Sherrid, Mark V., David Z. Gunsburg, & Ajay Sharma. (2000). Medical treatment of hypertrophic cardiomyopathy. Current Cardiology Reports. 2(2). 148–153. 4 indexed citations

17.

Sherrid, Mark V., et al.. (2000). Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 36(4). 1344–1354. 196 indexed citations

18.

Sherrid, Mark V., et al.. (1993). An echocardiographic study of the fluid machanics of obstruction in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 22(3). 816–825. 126 indexed citations

19.

Kereiakes, Dean J., W.Douglas Weaver, Jeffrey L. Anderson, et al.. (1990). Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities Report from the Pre-hospital Study Group and the Cincinnati Heart Project. American Heart Journal. 120(4). 773–780. 149 indexed citations

20.

Sherrid, Mark V., et al.. (1990). A pilot study of paramedic‐administered, prehospital thrombolysis for acute myocardial infarction. Clinical Cardiology. 13(6). 421–424. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact